On Jun 27, 2018 Transenterix Inc (NYSEAMERICAN:TRXC) Shorts Rose By 2.45%

June 27, 2018 - By Jeanette Garcia

TransEnterix, Inc. (NYSEAMERICAN:TRXC) Corporate Logo

Big Money Sentiment decreased to 1.64 in Q1 2018. It has change of 0.56, from 2017Q4’s 2.2. The ratio worsened due to TransEnterix, Inc. positioning: 13 sold and 12 reduced. 20 funds amassed stakes and 21 increased stakes. Investors holded 50.72 million in 2017Q4 but now own 50.28 million shares or 0.87% less.
Susquehanna Int Gp Limited Liability Partnership stated it has 1.51M shs. 154,568 are held by Lpl Fincl Ltd Liability Company. Balyasny Asset Ltd Liability Com has invested 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Northern, Illinois-based fund reported 267,381 shs. Wells Fargo & Communications Mn invested 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Element Cap Ltd Liability reported 202,406 shs or 0.01% of all its holdings. Cwm Ltd Liability Company holds 0% or 1,000 shs in its capital. Comml Bank Of America Corporation De owns 61,524 shs. The New York-based Jpmorgan Chase And Company has invested 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Weiss Asset Mngmt Limited Partnership reported 18,400 shs. Aisling Cap Lc, New York-based fund reported 9.89M shs. The Florida-based Raymond James Financial Ser has invested 0% in TransEnterix, Inc. (NYSEAMERICAN:TRXC). Pura Vida Limited Co has 0% invested in TransEnterix, Inc. (NYSEAMERICAN:TRXC) for 780,532 shs. Eagle Asset Mngmt accumulated 312,879 shs. Bowling Portfolio owns 20,000 shs or 0% of their US capital.

TransEnterix, Inc. had 2 insider sales and 0 buys since June 1, 2018. This’s net activity of $1.26 million. On Monday, June 18 the insider SLATTERY JOSEPH P sold $1.16 million.

Change of 2.45% for Transenterix Inc (NYSEAMERICAN:TRXC)’s shares shorted was showed. FINRA published shares shorted of TRXC’s total 23.29 million shares. The up change of 2.45% from 22.74 million shares was reported. 14 days will cost TRXC with 1.70 million average volume to recover its previous position.

TRXC is reaching $5.31 during the last trading session, after increased 7.06%.TransEnterix, Inc. has 18.88M shares volume, 278.71% up from normal. TRXC is uptrending and has moved 552.08% since June 27, 2017. TRXC outperformed the S&P 500 by 539.51%.

TransEnterix, Inc., a medical device company, focuses on the development and commercialization of surgical robotic systems.The company has $1.08 billion market cap. The firm offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe.Last it reported negative earnings. It also develops SurgiBot System, a single-port, robotically enhanced laparoscopic surgical platform.

TransEnterix, Inc. (NYSEAMERICAN:TRXC) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.